Helpful Resources
INDICATION & LIMITATION OF USE

DESCOVY® for HIV-1 pre-exposure prophylaxis (PrEP) is indicated in at-risk adults and adolescents (≥35 kg) to reduce the risk of sexually acquired HIV-1 infection, excluding individuals at risk from receptive vaginal sex. HIV-1–negative status must be confirmed immediately prior to initiation.

Limitation of Use: DESCOVY FOR PrEP® is not indicated in individuals at risk of HIV-1 from receptive vaginal sex because effectiveness in this population has not been evaluated.

Helpful resources

Resources and tools for healthcare professionals

Below, you can find a variety of digital and downloadable resources designed with information about DESCOVY FOR PrEP® for you and your patients.

HCP=healthcare professional; STI=sexually transmitted infection; TAF=tenofovir alafenamide.